AIP
TVGN icon

Ameritas Investment Partners’s Tevogen Bio Holdings TVGN Stock Holding History

Ameritas Investment Partners’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$190 Sell
42
-1
-2% -$12 ﹤0.01% 3102
2025
Q4 		$710 Hold
43
– – ﹤0.01% 3118
2025
Q3 		$1.68K Hold
43
– – ﹤0.01% 3121
2025
Q2 		$2.68K Hold
43
– – ﹤0.01% 3156
2025
Q1 		$2.31K Hold
43
– – ﹤0.01% 3067
2024
Q4 		$2.21K Hold
43
– – ﹤0.01% 3096
2024
Q3 		$789 Hold
43
– – ﹤0.01% 3116
2024
Q2 		$1.55K Buy
+43
New +$2.8K ﹤0.01% 3100

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Ameritas Investment Partners's TVGN Position: Q1 2026 in Review

Ameritas Investment Partners reduced its Tevogen Bio Holdings (TVGN) stake by 2.3% in Q1 2026, selling an estimated $12 and leaving 42 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #3102.

Ameritas Investment Partners first reported a position in TVGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.68K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Ameritas Investment Partners held 42 shares of Tevogen Bio Holdings worth $190 as of Q1 2026.
  • Ameritas Investment Partners sold 1 Tevogen Bio Holdings share in Q1 2026, an estimated $12.
  • Tevogen Bio Holdings made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #3102 holding.
  • Ameritas Investment Partners first reported a position in Tevogen Bio Holdings in Q2 2024 and has held it in 8 quarters since.
  • Ameritas Investment Partners's Tevogen Bio Holdings position peaked at $2.68K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.